Chronic Pain & Energy Disorders We Treat

An estimated 50 million American adults live with chronic pain — and 19.6 million experience high-impact chronic pain that limits daily life or work, according to CDC surveillance data. Chronic fatigue syndrome affects roughly 3.3 million more. Migraines strike over 40 million. These are among the most prevalent and most poorly treated conditions in American medicine.

What they share is more important than what divides them. Neuroinflammation, mitochondrial dysfunction, HPA axis dysregulation, gut dysbiosis, nutrient depletion, and immune dysregulation are recurring themes across fibromyalgia, ME/CFS, chronic migraines, and persistent joint and muscle pain. Conventional care manages the symptom — the pain signal, the fatigue score, the headache frequency. Functional medicine investigates the biological environment producing those signals.

Fibromyalgia affects approximately 10 million Americans and remains one of the most diagnostically delayed and therapeutically frustrating conditions in medicine. The average patient sees multiple specialists over several years before receiving a diagnosis — and when the diagnosis does come, the standard treatment options are narrow: duloxetine, pregabalin, and milnacipran address central pain signaling but do not resolve the underlying biology driving the sensitization. The team at The Florida Center For Functional Medicine covers this approach in more depth.

Research published in peer-reviewed journals through 2024 and 2025 has deepened the biological picture considerably. Dysregulation of the HPA axis and sympathetic nervous system, neuroinflammation at the level of dorsal root ganglia, low-grade systemic inflammation with cytokine imbalance, mitochondrial dysfunction, and gut dysbiosis have all been identified as contributing mechanisms. This is not a condition without a cause — it is a condition whose causes have been systematically underinvestigated in clinical practice. To explore Research published peer-reviewed journals further, see this detailed guide.

A functional medicine approach to fibromyalgia begins with a comprehensive biological mapping: inflammatory markers (hs-CRP, IL-6, TNF-alpha where indicated), cortisol rhythm and HPA axis assessment, mitochondrial function markers (organic acids panel), gut microbiome analysis, nutrient status (magnesium, B vitamins, CoQ10, vitamin D), sleep quality evaluation including sleep apnea screening, and food sensitivity testing. Treatment addresses the identified drivers in sequence — reducing inflammatory and neurological load while restoring the biological resources the nervous system needs to down-regulate pain. For a deeper look at functional medicine approach fibromyalgia, see our guide to guide to metabolic health functional.

According to the CDC NCHS Data Brief (December 2023), approximately 1.3% of US adults — roughly 3.3 million people — have ME/CFS, with women affected at nearly twice the rate of men. The true prevalence is likely higher, as the majority of cases remain undiagnosed. Post-COVID illness has further increased the number of people presenting with ME/CFS-pattern symptoms, bringing long-overdue research attention to a condition that has been dismissed for decades.

Post-exertional malaise — the hallmark feature of ME/CFS — is physiologically distinct from ordinary fatigue. Physical or cognitive exertion beyond a patient’s energy envelope triggers a delayed worsening of all symptoms, often lasting days. This is not deconditioning. Research identifies abnormal energy metabolism, mitochondrial dysfunction, immune dysregulation including NK cell hypofunction, autonomic nervous system disruption (POTS and orthostatic intolerance), reactivation of latent viruses including EBV and HHV-6, and gut microbiome disruption as recurring findings.

Functional medicine evaluation of ME/CFS focuses on the measurable biology: viral reactivation panels, NK cell activity, organic acids (mitochondrial function markers), cortisol and autonomic function testing, comprehensive nutrient assessment, gut microbiome and permeability, and inflammatory cytokine profiles. Treatment is pacing-first — protecting the patient from the energy envelope violation that causes crashes — while systematically addressing the underlying immune, mitochondrial, and autonomic dysfunction. Learn more about autoimmune disease functional medicine and how it applies to Functional medicine evaluation ME/CFS.

Migraines affect over 40 million Americans and are the sixth most common reason for emergency department visits. Women between 18 and 44 are most affected, with a three-month prevalence of migraine or severe headache exceeding 23%. Despite their prevalence and disability burden, migraines are frequently undertreated — and the treatments most commonly offered address the acute attack rather than the triggers and biological terrain producing repeated attacks.

Functional medicine approaches migraine as a condition with identifiable triggers and underlying biological susceptibilities — not as an inevitable neurological fate. The most consistently identified functional contributors include hormonal fluctuations (particularly estrogen changes during the menstrual cycle and perimenopause), magnesium deficiency (documented in a significant proportion of migraine patients), mitochondrial dysfunction, food sensitivities and dietary triggers, gut dysbiosis and increased intestinal permeability, sleep dysregulation, and inflammatory load. If you’re exploring Functional medicine approaches migraine, hormonal imbalance functional strategies covers this in more depth.

Our evaluation includes a complete hormonal and nutrient assessment (magnesium RBC, riboflavin/B2, CoQ10, vitamin D), gut microbiome and permeability testing, food sensitivity panel, cortisol rhythm assessment, and detailed trigger mapping. Many patients experience dramatic reductions in migraine frequency through targeted nutritional repletion, dietary modification, and hormonal balancing alone — before any pharmaceutical intervention is considered.

Joint and muscle pain that does not have an obvious structural explanation — or that is more widespread, more persistent, or more debilitating than imaging findings would predict — is almost always a systemic signal. Systemic inflammation from gut dysbiosis, food sensitivities, metabolic dysfunction, or autoimmune activity drives joint inflammation that presents identically to mechanical arthritis on standard workup. Nutrient deficiencies — particularly vitamin D, magnesium, omega-3 fatty acids, and B12 — are directly involved in muscle function, nerve conduction, and inflammatory regulation.

Patients in this category are often told their imaging is ‘not bad enough’ to explain their pain level, or are cycled through NSAIDs, physical therapy, and cortisone injections without investigation of the inflammatory biology driving the pain. Others are tested for rheumatoid factor or ANA and, when those return negative, are reassured that nothing autoimmune is occurring — despite the fact that many autoimmune and inflammatory conditions produce significant joint and muscle symptoms well before serological markers become positive.

Functional evaluation includes a full inflammatory panel (hs-CRP, ESR, homocysteine, inflammatory cytokines), food sensitivity testing, gut microbiome and permeability assessment, comprehensive nutrient status, hormonal markers (particularly testosterone, DHEA, and cortisol, which directly govern muscle recovery and joint integrity), and where relevant, an expanded autoimmune antibody panel that goes beyond the standard screening tests.

Fibromyalgia, ME/CFS, chronic migraines, and persistent joint and muscle pain share a biological architecture that conventional specialty silos are poorly positioned to see. Neuroinflammation — low-grade immune activation within the central and peripheral nervous systems — amplifies pain signaling, disrupts sleep architecture, impairs cognitive function, and perpetuates fatigue cycles. Mitochondrial dysfunction impairs cellular energy production, leaving the body unable to meet physiological demand and recover normally from exertion. Gut dysbiosis maintains a constant inflammatory signal that drives central sensitization. HPA axis dysregulation alters cortisol patterns, which directly governs inflammation, sleep, immune function, and pain threshold. Peripheral Neuropathy Specialists in Florida goes deeper on the specifics.

These are not four separate problems. They are four expressions of a shared biological terrain — and patients who present with more than one of these conditions simultaneously (which is common) are usually displaying different facets of the same underlying dysfunction. Treating each diagnosis independently with its own specialist and medication, while leaving the shared terrain unchanged, is why so many patients cycle through years of care without meaningful improvement.

Our practice evaluates that shared terrain systematically. We look for the convergence of findings — where inflammation, nutrient depletion, dysbiosis, and HPA dysregulation overlap in your specific biology — and we build a treatment sequence that addresses the foundation rather than managing each symptom in isolation.